ZA200006123B - Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides. - Google Patents
Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides.Info
- Publication number
- ZA200006123B ZA200006123B ZA200006123A ZA200006123A ZA200006123B ZA 200006123 B ZA200006123 B ZA 200006123B ZA 200006123 A ZA200006123 A ZA 200006123A ZA 200006123 A ZA200006123 A ZA 200006123A ZA 200006123 B ZA200006123 B ZA 200006123B
- Authority
- ZA
- South Africa
- Prior art keywords
- feline
- ctla
- provides
- nucleic acid
- present
- Prior art date
Links
- 241000282324 Felis Species 0.000 title abstract 20
- 108010021064 CTLA-4 Antigen Proteins 0.000 title abstract 5
- 229940045513 CTLA4 antagonist Drugs 0.000 title abstract 5
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 title abstract 5
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 title abstract 5
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 title abstract 5
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 title abstract 5
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 title abstract 5
- 102000039446 nucleic acids Human genes 0.000 title abstract 4
- 108020004707 nucleic acids Proteins 0.000 title abstract 4
- 150000007523 nucleic acids Chemical class 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 239000013598 vector Substances 0.000 abstract 5
- 229960005486 vaccine Drugs 0.000 abstract 4
- 230000028993 immune response Effects 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Transplantation (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7169998A | 1998-05-01 | 1998-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200006123B true ZA200006123B (en) | 2002-01-20 |
Family
ID=22102998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200006123A ZA200006123B (en) | 1998-05-01 | 2000-10-30 | Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1073741B1 (hu) |
| JP (3) | JP2002513571A (hu) |
| KR (2) | KR20040053251A (hu) |
| AT (1) | ATE481485T1 (hu) |
| AU (1) | AU4070399A (hu) |
| BR (1) | BR9910153A (hu) |
| CA (1) | CA2327539A1 (hu) |
| CZ (1) | CZ20003935A3 (hu) |
| DE (1) | DE69942765D1 (hu) |
| ES (1) | ES2352745T3 (hu) |
| HK (1) | HK1034537A1 (hu) |
| HU (1) | HUP0102806A3 (hu) |
| IL (4) | IL139371A0 (hu) |
| NO (1) | NO20005481L (hu) |
| NZ (1) | NZ507794A (hu) |
| PL (1) | PL199352B1 (hu) |
| RU (2) | RU2377302C2 (hu) |
| SK (1) | SK16172000A3 (hu) |
| UA (2) | UA87470C2 (hu) |
| WO (1) | WO1999057271A2 (hu) |
| ZA (1) | ZA200006123B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
| CA2411828A1 (en) | 2000-06-23 | 2002-01-03 | Maxygen, Inc. | Novel co-stimulatory molecules |
| US7183376B2 (en) | 2000-06-23 | 2007-02-27 | Maxygen, Inc. | Variant B7 co-stimulatory molecules |
| AU2013207191B2 (en) * | 2012-01-05 | 2017-10-26 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers |
| CN110184283A (zh) * | 2019-04-30 | 2019-08-30 | 吉林农业大学 | 一种检测虎细小病毒的lamp-lfd试剂盒 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658669B1 (fr) * | 1990-02-20 | 1992-07-24 | Souriau & Cie | Connecteur a verrouillage par levier. |
| WO1995006738A1 (en) * | 1993-09-03 | 1995-03-09 | Schering Corporation | B70(b7-2):ctla-4 bonding protein |
| PT784483E (pt) * | 1994-10-03 | 2001-05-31 | Us Gov Health & Human Serv | Composicao que compreende um virus recombinante que exprime um antigenio e um virus recombinante que exprime uma molecula imunoestimuladora |
| JP4025400B2 (ja) * | 1997-04-16 | 2007-12-19 | 財団法人化学及血清療法研究所 | 新規免疫制御分子及びその製造方法 |
-
1999
- 1999-04-30 EP EP99924130A patent/EP1073741B1/en not_active Expired - Lifetime
- 1999-04-30 HU HU0102806A patent/HUP0102806A3/hu not_active Application Discontinuation
- 1999-04-30 KR KR10-2004-7006622A patent/KR20040053251A/ko not_active Application Discontinuation
- 1999-04-30 UA UAA200603428A patent/UA87470C2/ru unknown
- 1999-04-30 AT AT99924130T patent/ATE481485T1/de not_active IP Right Cessation
- 1999-04-30 ES ES99924130T patent/ES2352745T3/es not_active Expired - Lifetime
- 1999-04-30 SK SK1617-2000A patent/SK16172000A3/sk unknown
- 1999-04-30 AU AU40703/99A patent/AU4070399A/en not_active Abandoned
- 1999-04-30 UA UA2000116864A patent/UA77382C2/uk unknown
- 1999-04-30 RU RU2005108676/13A patent/RU2377302C2/ru not_active IP Right Cessation
- 1999-04-30 RU RU2000130225/13A patent/RU2263145C2/ru not_active IP Right Cessation
- 1999-04-30 IL IL13937199A patent/IL139371A0/xx unknown
- 1999-04-30 NZ NZ507794A patent/NZ507794A/en unknown
- 1999-04-30 JP JP2000547226A patent/JP2002513571A/ja not_active Withdrawn
- 1999-04-30 DE DE69942765T patent/DE69942765D1/de not_active Expired - Lifetime
- 1999-04-30 CA CA002327539A patent/CA2327539A1/en not_active Abandoned
- 1999-04-30 PL PL345975A patent/PL199352B1/pl not_active IP Right Cessation
- 1999-04-30 KR KR1020007012138A patent/KR100869861B1/ko not_active IP Right Cessation
- 1999-04-30 WO PCT/US1999/009502 patent/WO1999057271A2/en active Application Filing
- 1999-04-30 CZ CZ20003935A patent/CZ20003935A3/cs unknown
- 1999-04-30 BR BR9910153-0A patent/BR9910153A/pt not_active Application Discontinuation
-
2000
- 2000-10-30 IL IL139371A patent/IL139371A/en not_active IP Right Cessation
- 2000-10-30 ZA ZA200006123A patent/ZA200006123B/xx unknown
- 2000-10-31 NO NO20005481A patent/NO20005481L/no not_active Application Discontinuation
-
2001
- 2001-07-20 HK HK01105096.1A patent/HK1034537A1/xx not_active IP Right Cessation
-
2007
- 2007-06-25 IL IL184202A patent/IL184202A/en not_active IP Right Cessation
- 2007-06-25 IL IL184201A patent/IL184201A/en not_active IP Right Cessation
-
2009
- 2009-12-02 JP JP2009274978A patent/JP2010104369A/ja active Pending
-
2010
- 2010-07-16 JP JP2010161913A patent/JP2010252804A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1999058658A3 (en) | Expression vectors for stimulating an immune response and methods of using the same | |
| BR0010361A (pt) | Seq ências genÈmicas de neisseria e uso destas | |
| SG145767A1 (en) | Improvements in vaccination | |
| SG152917A1 (en) | Neisseria meningitidis antigens | |
| AU2003278729A8 (en) | Regulated bacterial lysis for gene vaccine vector delivery and antigen release | |
| MXPA00010722A (es) | Antigenos de neisseria meningitidis y composiciones que los contienen. | |
| WO2002083738A1 (fr) | Anticorps trispecifique monocatenaire cyclique | |
| ZA200006123B (en) | Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides. | |
| HU9801384D0 (en) | Clostridium perfringeus vaccine | |
| MXPA04003969A (es) | Sistema de expresion de acido nucleico regulado. | |
| DE69922212D1 (de) | Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp) | |
| NO20005482L (no) | Rekombinant virus og anvendelser derav samt vaksine som omfatter nevnte virus. | |
| IL149415A0 (en) | Adjuvanted genetic vaccines | |
| WO2000063242A8 (en) | Chimeric lyssavirus nucleic acids and polypeptides | |
| WO2001032204A3 (en) | Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression | |
| SI1227840T1 (sl) | Genetske vakcine z adjuvansom | |
| NZ334649A (en) | Iron regulated promoter derived from an aerobactin gene promoter | |
| EP1496121A3 (en) | Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |